GUIDANCE DOCUMENT
Dosage Delivery Devices for Orally Ingested OTC Liquid Drug Products May 2011
- Docket Number:
- FDA-2009-D-0322
- Issued by:
-
Guidance Issuing OfficeCenter for Drug Evaluation and Research
This document is intended to provide guidance to firms that are manufacturing, marketing, or distributing orally ingested over-the-counter (OTC) liquid drug products (e.g., elixirs, suspensions, solutions, syrups) that are packaged with dosage delivery devices (e.g., calibrated cups, droppers, syringes, spoons).
Submit Comments
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: FDA-2009-D-0322 .